Predictions
InMed Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1.30
20.03.23
20.03.23
-
20.03.24
20.03.24
6.18%
23.03.23
23.03.23
Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€26.85
14.03.22
14.03.22
€40.00
14.03.23
14.03.23
36.78%
11.03.23
11.03.23
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Promis Neurosciences Inc.
Start price
Target price
Perf. (%)
€5.37
21.07.22
21.07.22
€5.30
21.07.23
21.07.23
-21.42%
11.03.23
11.03.23
ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Eco Atlantic Oil and Gas Ltd
Start price
Target price
Perf. (%)
€0.37
24.02.22
24.02.22
-
24.02.23
24.02.23
-36.56%
25.02.23
25.02.23
Fortuna Silver Mines Inc.
Start price
Target price
Perf. (%)
€3.32
14.11.22
14.11.22
-
14.11.23
14.11.23
-8.52%
24.02.23
24.02.23
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Rising EBIT margin expected
Revenue growth > 30% per year expected
Denison Mines Corp.
Start price
Target price
Perf. (%)
€1.31
25.01.23
25.01.23
-
25.01.24
25.01.24
-14.12%
24.02.23
24.02.23
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
First Majestic Silver Corp.
Start price
Target price
Perf. (%)
€10.10
21.02.22
21.02.22
-
21.02.23
21.02.23
-35.47%
22.02.23
22.02.23
Could be very worthwhile Investment >20% year
Lithium Americas Corp.
Start price
Target price
Perf. (%)
€25.70
10.02.22
10.02.22
€33.00
10.02.23
10.02.23
-8.75%
11.02.23
11.02.23
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Future proof or reliable business model
Low dividend yield expected
New Gold Inc.
Start price
Target price
Perf. (%)
€1.51
08.02.22
08.02.22
€1.85
08.02.23
08.02.23
-35.14%
09.02.23
09.02.23
Could be worthwhile Investment >10% per year
Capable Management
Future proof or reliable business model
Ur-Energy Inc.
Start price
Target price
Perf. (%)
€1.05
07.02.22
07.02.22
-
07.02.23
07.02.23
8.29%
08.02.23
08.02.23
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Growths faster than the competition
Future proof or reliable business model
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€3.70
05.02.22
05.02.22
€10.00
05.02.23
05.02.23
-72.82%
06.02.23
06.02.23
Could be worthwhile Investment >10% per year
positive Cash Flow expected
Standard Investments for future growth
EBIT decline/stagnation expected
Nexgen Energy Ltd
Start price
Target price
Perf. (%)
€3.69
05.02.22
05.02.22
€6.00
05.02.23
05.02.23
12.57%
06.02.23
06.02.23
Could be worthwhile Investment >10% per year
Fair valuation
positive Cash Flow expected
Mag Silver Corp.
Start price
Target price
Perf. (%)
€12.89
17.10.22
17.10.22
-
17.10.23
17.10.23
-2.21%
30.01.23
30.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Lithium Americas Corp.
Start price
Target price
Perf. (%)
€22.14
29.01.22
29.01.22
€28.00
29.01.23
29.01.23
-5.17%
30.01.23
30.01.23
Could be worthwhile Investment >10% per year
Nano One Materials Corp
Start price
Target price
Perf. (%)
€2.20
28.01.22
28.01.22
-
28.01.23
28.01.23
-8.43%
29.01.23
29.01.23
Could be worthwhile Investment >10% per year
Jaguar Mining Inc.
Start price
Target price
Perf. (%)
€2.05
17.10.22
17.10.22
-
17.10.23
17.10.23
-4.87%
23.01.23
23.01.23
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Aurora Cannabis Inc.
Start price
Target price
Perf. (%)
€1.50
21.07.22
21.07.22
€1.00
21.07.23
21.07.23
-44.89%
11.01.23
11.01.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Energy Fuels Inc.
Start price
Target price
Perf. (%)
€5.78
13.12.22
13.12.22
-
13.12.23
13.12.23
8.44%
11.01.23
11.01.23
Revenue growth > 30% per year expected
Could be very worthwhile Investment >20% year
EBIT growth > 30% per year expected
Aptose Biosciences
Start price
Target price
Perf. (%)
€0.98
14.12.21
14.12.21
-
14.12.22
14.12.22
-39.08%
15.12.22
15.12.22
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€4.85
01.12.21
01.12.21
-
01.12.22
01.12.22
-53.67%
02.12.22
02.12.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Stable Large shareholder and/or long term investor
Future proof or reliable business model
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.05
20.09.22
20.09.22
€1.80
20.09.23
20.09.23
36.59%
19.11.22
19.11.22
Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected